Andrea Vignali
Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele
Papers
3
Total Citations
102
H-Index
3
About
Andrea Vignali is a leading colorectal surgeon whose research is reshaping the landscape of minimally invasive rectal cancer surgery. His primary focus is on advancing surgical techniques to improve patient outcomes, with key contributions in transanal total mesorectal excision (TaTME) and intraoperative fluorescence imaging. Vignali’s most impactful work, the landmark IntAct trial (2025), is a rare, unblinded randomised controlled trial that rigorously tested indocyanine green (ICG) fluorescence angiography to prevent anastomotic leaks—a devastating complication in rectal surgery. This study, already garnering 29 citations, provides critical, high-level evidence for a technique that could become standard practice. His earlier work on TaTME (60 citations) established a comprehensive overview of this innovative approach, while his multicenter study on segmental transverse colectomy (13 citations) clarified the benefits of laparoscopic and robotic methods over open surgery for transverse colon cancer. By combining rigorous clinical trials with practical surgical insights, Vignali is directly translating research into safer, more effective operations, making him a pivotal figure in the evolution of colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3